An open‐label clinical trial of the effects of age and gender on the pharmacodynamics, pharmacokinetics and safety of the ghrelin receptor agonist anamorelin

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 2, 2015-03 ,pp. : 112-120

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Rifampicin (Rifampin) on the Pharmacokinetics and Safety of Ambrisentan in Healthy Subjects: A Single-Sequence, Open-Label Study

By Harrison Brooke  

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 875-885

Adis International

Access to resources Recommend Favorite

Effect of Steady-State Ambrisentan on the Pharmacokinetics of a Single Dose of the Oral Contraceptive Norethindrone (Norethisterone) 1 mg/Ethinylestradiol 35 μg in Healthy Subjects: An Open-Label, Single-Sequence, Single-Centre Study

By Spence Rebecca   Mandagere Arun   Walker Gennyne   Dufton Christopher   Boinpally Ramesh  

Clinical Drug Investigation, Vol. 30, Iss. 5, 2010-05 ,pp. : 313-324

Adis International

Access to resources Recommend Favorite

Effect of Intrinsic and Extrinsic Factors on the Clinical Pharmacokinetics and Pharmacodynamics of Prasugrel

By Small David S.  

Clinical Pharmacokinetics, Vol. 49, Iss. 12, 2010-12 ,pp. : 777-798

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Cinacalcet in Hepatic Impairment: Phase I, Open-Label, Parallel-Group, Single-Dose, Single-Centre Study

By Padhi Desmond  

Clinical Drug Investigation, Vol. 28, Iss. 10, 2008-01 ,pp. : 635-643

Adis International

Access to resources Recommend Favorite